Literature DB >> 17991872

TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of Src and PLC.

Agneta Siegbahn1, Matilda Johnell, Anna Nordin, Mikael Aberg, Teet Velling.   

Abstract

BACKGROUND: We have previously reported the potentiation of PDGF-BB-induced chemotaxis of fibroblasts, vascular smooth muscle cells, and endothelial cells by FVIIa. Here we studied the role of TF/FVIIa and the induced signaling pathways in regulation of chemotaxis of human monocytes, fibroblasts, and porcine aorta endothelial cells. METHODS AND
RESULTS: Human monocytes were obtained by using Ficoll-Paque gradient and the MACS system (for highly purified population), fibroblasts and PAE cells have been characterized previously. Inhibitors of selected signaling intermediates were used, and the effect of TF/FVIIa on the migratory response of all cells to chemotactic agents was analyzed. The induced signaling was studied by immunoprecipitation and Western blotting. TF/FVIIa complex selectively enhanced PDGF-BB-induced chemotaxis in a Src-family, PLC, and PAR-2-dependent manner. Using PAE cells we identified c-Src and c-Yes as the Src-family members activated by TF/FVIIa. We report for the first time the PAR-2 and Src family-dependent transactivation of PDGFRbeta by TF/FVIIa involving phosphorylation of a subset of PDGFRbeta tyrosines.
CONCLUSIONS: The described transactivation is a likely mechanism of TF/FVIIa-mediated regulation of PDGF-BB-induced chemotaxis. Similar behavior of 3 principally different cell types in our experimental setup may reflect a general function of TF in regulation of cell migration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991872     DOI: 10.1161/ATVBAHA.107.155754

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

1.  Growth factors outside the PDGF family drive experimental PVR.

Authors:  Hetian Lei; Gisela Velez; Peter Hovland; Tatsuo Hirose; Debra Gilbertson; Andrius Kazlauskas
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

2.  Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53.

Authors:  Hetian Lei; Gisela Velez; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2011-02-28       Impact factor: 4.272

3.  Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia.

Authors:  Steven Pennock; Leo A Kim; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

Review 4.  Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.

Authors:  P J Little; M D Hollenberg; D Kamato; W Thomas; J Chen; T Wang; W Zheng; N Osman
Journal:  Br J Pharmacol       Date:  2016-02-16       Impact factor: 8.739

5.  Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation.

Authors:  Franziska Mußbach; Petra Henklein; Martin Westermann; Utz Settmacher; Frank-D Böhmer; Roland Kaufmann
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-06       Impact factor: 4.553

Review 6.  Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.

Authors:  Hetian Lei; Marc-Andre Rheaume; Andrius Kazlauskas
Journal:  Exp Eye Res       Date:  2009-11-25       Impact factor: 3.467

Review 7.  Targeting clotting proteins in cancer therapy - progress and challenges.

Authors:  Wolfram Ruf; Andrea S Rothmeier; Claudine Graf
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

8.  Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells.

Authors:  Hetian Lei; Andrius Kazlauskas
Journal:  J Biol Chem       Date:  2009-01-06       Impact factor: 5.157

9.  Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.

Authors:  Andrea S Rothmeier; Enbo Liu; Sagarika Chakrabarty; Jennifer Disse; Barbara M Mueller; Henrik Østergaard; Wolfram Ruf
Journal:  Blood       Date:  2017-12-15       Impact factor: 22.113

10.  The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.

Authors:  Oskar Eriksson; Margareta Ramström; Katarina Hörnaeus; Jonas Bergquist; Dariush Mokhtari; Agneta Siegbahn
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.